Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Molecular Medicine Congress

Raymond Schiffelers's Biography



Raymond Schiffelers, Professor of Nanomedicine, University Medical Center Utrecht

Raymond Schiffelers studied Bio-Pharmaceutical Sciences at Leiden University (1990-1995). After an industrial traineeship at SmithKline Beecham Pharmaceuticals (UK) he did his PhD in medical microbiology at Erasmus University Rotterdam on liposomal targeting of antimicrobial agents (1996-2001). Subsequently he became post-doc at Utrecht University working on liposomes targeting tumor vasculature. In 2002-2003, at Intradigm Co (USA) he expanded his tumor vasculature-targeting work with polymers for delivery of siRNA. After his return to Utrecht University he became assistant and then associate professor. He received an ERC Consolidator Grant in 2010 to investigate extracellular vesicles as biological drug delivery systems. After he moved to University Medical Center Utrecht in 2011 he became professor of nanomedicine working on bio-inspired and synthetic drug delivery systems. He coordinates two H2020 projects on this topic, B-SMART and EXPERT, is editor for the International Journal of Pharmaceutics, Journal of Controlled Release and Journal of Extracellular Vesicles, and is founder of EXCYTEX-an extracellular vesicle-based company. Since 2021 he also works part-time for Nanocell Therapeutics as VP Preclinical R&D and is president of the ETPN.

Raymond Schiffelers Image

Exosomes and Microvesicles in the Circulation

Wednesday, 4 September 2013 at 08:45

Add to Calendar ▼2013-09-04 08:45:002013-09-04 09:45:00Europe/LondonExosomes and Microvesicles in the CirculationMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com

Blood cells respond to stress with release of extracellular vesicles. In particular red blood cells are prone to vesicle release upon a range of stress signals which can range from mechanical stress (e.g. during cardiopumonary bypass procedures) or chemical stress after pharmaceutical intervention (e.g. Taxol). These vesicles carry phosphatidylserine which is thrombogeneic, and carry iron/heme which can cause oxidative stress.


Add to Calendar ▼2013-09-03 00:00:002013-09-04 00:00:00Europe/LondonMolecular Medicine CongressMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com